Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D2 | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D4 | Starlite/ChEMBL | References |
Homo sapiens | dopamine receptor D3 | Starlite/ChEMBL | References |
Homo sapiens | 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | hypothetical protein | dopamine receptor D3 | 400 aa | 392 aa | 19.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.034 | 0 | 0.5 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0478 | 0.0164 | 0.0164 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.034 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.034 | 0 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.034 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein, conserved | 0.8733 | 1 | 1 |
Echinococcus multilocularis | tm gpcr rhodopsin gpcr rhodopsin superfamily | 0.1023 | 0.0814 | 0.0814 |
Trypanosoma cruzi | Diacylglycerol kinase catalytic domain containing protein, putative | 0.034 | 0 | 0.5 |
Mycobacterium tuberculosis | Conserved protein | 0.8733 | 1 | 1 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase-like protein, putative | 0.034 | 0 | 0.5 |
Onchocerca volvulus | Ceramide kinase 1 homolog | 0.034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.034 | 0 | 0.5 |
Onchocerca volvulus | 0.034 | 0 | 0.5 | |
Trypanosoma brucei | Diacylglycerol kinase catalytic domain containing protein, putative | 0.034 | 0 | 0.5 |
Leishmania major | diacylglycerol kinase-like protein | 0.034 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase accessory domain (presumed) domain-containing protein | 0.034 | 0 | 0.5 |
Leishmania major | hypothetical protein, conserved | 0.034 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.034 | 0 | 0.5 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.034 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.034 | 0 | 0.5 |
Trypanosoma brucei | Sphingosine kinase | 0.034 | 0 | 0.5 |
Trypanosoma brucei | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trypanosoma cruzi | Sphingosine kinase | 0.034 | 0 | 0.5 |
Trichomonas vaginalis | sphingosine kinase, putative | 0.034 | 0 | 0.5 |
Trichomonas vaginalis | bmru protein, putative | 0.034 | 0 | 0.5 |
Plasmodium vivax | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Toxoplasma gondii | diacylglycerol kinase catalytic domain-containing protein | 0.034 | 0 | 0.5 |
Echinococcus multilocularis | biogenic amine (5HT) receptor | 0.0478 | 0.0164 | 0.0164 |
Mycobacterium ulcerans | hypothetical protein | 0.8733 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.8733 | 1 | 1 |
Trichomonas vaginalis | diacylglycerol kinase, epsilon, putative | 0.034 | 0 | 0.5 |
Leishmania major | sphingosine kinase A, B, putative | 0.034 | 0 | 0.5 |
Schistosoma mansoni | sphingosine kinase A B | 0.8733 | 1 | 1 |
Brugia malayi | Serotonin receptor | 0.0579 | 0.0284 | 1 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0478 | 0.0164 | 0.0164 |
Trichomonas vaginalis | diacylglycerol kinase, zeta, iota, putative | 0.034 | 0 | 0.5 |
Trypanosoma cruzi | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Leishmania major | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trichomonas vaginalis | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Trichomonas vaginalis | bmru protein, putative | 0.034 | 0 | 0.5 |
Schistosoma mansoni | sphingoid long chain base kinase | 0.8733 | 1 | 1 |
Echinococcus multilocularis | sphingosine kinase 1 | 0.8733 | 1 | 1 |
Echinococcus granulosus | tm gpcr rhodopsin | 0.1023 | 0.0814 | 0.0814 |
Plasmodium falciparum | diacylglycerol kinase, putative | 0.034 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 11 nM | Displacement of [3H]LSD from human 5HT6 receptor expressed in HEK293 cells | ChEMBL. | 21190848 |
IC50 (binding) | = 19 nM | Displacement of [3H]mesulergine from human 5HT2C receptor expressed in cells | ChEMBL. | 21190848 |
IC50 (binding) | = 180 nM | Displacement of [3H]spiperone from human dopamine D3 receptor expressed in cells | ChEMBL. | 21190848 |
IC50 (binding) | = 704 nM | Displacement of [3H]ketanserin from human 5HT2A receptor expressed in cells | ChEMBL. | 21190848 |
IC50 (binding) | = 1226 nM | Displacement of [3H]8-OH-DPAT from human 5HT1A receptor expressed in cells | ChEMBL. | 21190848 |
IC50 (binding) | = 1784 nM | Displacement of [3H]spiperone from human dopamine D2 receptor expressed in cells | ChEMBL. | 21190848 |
IC50 (binding) | > 10000 nM | Displacement of [3H]LSD from human 5HT7 receptor expressed in cells | ChEMBL. | 21190848 |
IC50 (binding) | > 10000 nM | Displacement of [3H]spiperone from human dopamine D4 receptor expressed in cells | ChEMBL. | 21190848 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.